127 related articles for article (PubMed ID: 11917226)
21. Significantly decreased P27 expression in endometrial carcinoma compared to complex hyperplasia with atypia (correlation with p53 expression).
Ozkara SK; Corakci A
Pathol Oncol Res; 2004; 10(2):89-97. PubMed ID: 15188025
[TBL] [Abstract][Full Text] [Related]
22. Dissociated expression of Bcl-2 and Ki-67 in endometrial lesions: diagnostic and histogenetic implications.
Risberg B; Karlsson K; Abeler V; Lagrelius A; Davidson B; Karlsson MG
Int J Gynecol Pathol; 2002 Apr; 21(2):155-60. PubMed ID: 11917225
[TBL] [Abstract][Full Text] [Related]
23. Computerized image analysis of p53 and proliferating cell nuclear antigen expression in benign, hyperplastic, and malignant endometrium.
Elhafey AS; Papadimitriou JC; El-Hakim MS; El-Said AI; Ghannam BB; Silverberg SG
Arch Pathol Lab Med; 2001 Jul; 125(7):872-9. PubMed ID: 11419970
[TBL] [Abstract][Full Text] [Related]
24. Altered tenascin expression during spontaneous endometrial carcinogenesis in the BDII/Han rat.
Vollmer G; Deerberg F; Siegal GP; Knuppen R
Virchows Arch B Cell Pathol Incl Mol Pathol; 1991; 60(2):83-9. PubMed ID: 1710855
[TBL] [Abstract][Full Text] [Related]
25. [Assessment of the PCNA and P53 proteins expression in the proliferative, hyperplastic and neoplastic human endometrium].
Zawiślak W; Semczuk A; Miturski R
Ginekol Pol; 2001 Dec; 72(12A):1549-54. PubMed ID: 11883313
[TBL] [Abstract][Full Text] [Related]
26. Malignant transformation of the human endometrium is associated with overexpression of lactoferrin messenger RNA and protein.
Walmer DK; Padin CJ; Wrona MA; Healy BE; Bentley RC; Tsao MS; Kohler MF; McLachlan JA; Gray KD
Cancer Res; 1995 Mar; 55(5):1168-75. PubMed ID: 7867003
[TBL] [Abstract][Full Text] [Related]
27. Cathepsin D expression in normal, hyperplastic and malignant endometrial tissue: an immunohistochemical analysis.
Mylonas I; Makovitzky J; Richter DU; Jeschke U; Briese V; Friese K
Acta Histochem; 2003; 105(3):245-52. PubMed ID: 13677618
[TBL] [Abstract][Full Text] [Related]
28. Sialosyl-Tn expression in normal and pathological conditions of human endometrium. An immunohistochemical study.
Semczuk A; Paszkowska A; Miturski R; Skomra D; Cybulski M; Jakowicki JA; Berbec H
Pathol Res Pract; 2002; 198(9):589-95. PubMed ID: 12440781
[TBL] [Abstract][Full Text] [Related]
29. FHIT expression in neoplastic, hyperplastic, and normal endometrium.
Ozkara SK; Corakçi A
Int J Gynecol Cancer; 2005; 15(6):1081-8. PubMed ID: 16343185
[TBL] [Abstract][Full Text] [Related]
30. [Expressions of aromatase protein and sex hormone receptor in endometrial lesions].
Ma XX; Zhang SL; Gao S; Lu JM; Dong F
Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):395-8. PubMed ID: 16831363
[TBL] [Abstract][Full Text] [Related]
31. Glycoprotein CD44 expression in normal, hyperplasic and neoplastic endometrium. An immunohistochemical study including correlations with p53, steroid receptor status and proliferative indices (PCNA, MIB1).
Zagorianakou N; Ioachim E; Mitselou A; Kitsou E; Zagorianakou P; Stefanaki S; Makrydimas G; Agnantis NJ
Eur J Gynaecol Oncol; 2003; 24(6):500-4. PubMed ID: 14658589
[TBL] [Abstract][Full Text] [Related]
32. Progesterone receptor expression and proliferative activity in uterine tumours of pet rabbits.
Vinci A; Bacci B; Benazzi C; Caldin M; Sarli G
J Comp Pathol; 2010 May; 142(4):323-7. PubMed ID: 20096851
[TBL] [Abstract][Full Text] [Related]
33. Inhibin (10.7 kD prostatic peptide) in normal, hyperplastic, and malignant human endometria: an immunohistochemical study.
Teni TR; Sampat MB; Sheth NA
J Pathol; 1992 Sep; 168(1):35-40. PubMed ID: 1453268
[TBL] [Abstract][Full Text] [Related]
34. Galectin-3 expression in normal, hyperplastic, and neoplastic endometrial tissues.
Brustmann H; Riss D; Naudé S
Pathol Res Pract; 2003; 199(3):151-8. PubMed ID: 12812316
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium.
Mitselou A; Ioachim E; Kitsou E; Vougiouklakis T; Zagorianakou N; Makrydimas G; Stefanaki S; Agnantis NJ
In Vivo; 2003; 17(5):469-77. PubMed ID: 14598611
[TBL] [Abstract][Full Text] [Related]
36. Enhanced CD24 expression in endometrial carcinoma and its expression pattern in normal and hyperplastic endometrium.
Kim KH; Choi JS; Kim JM; Choi YL; Shin YK; Lee HC; Seong IO; Kim BK; Chae SW; Kim SH
Histol Histopathol; 2009 Mar; 24(3):309-16. PubMed ID: 19130400
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical characterization of cancer antigen in uterine cancers.
Nur S; Chuang L; Ramaswamy G
Int J Gynecol Cancer; 2006; 16(5):1903-10. PubMed ID: 17009990
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical evaluation of PTEN protein in patients with endometrial intraepithelial neoplasia compared to endometrial adenocarcinoma and proliferative phase endometrium.
Cirpan T; Terek MC; Mgoyi L; Zekioglu O; Iscan O; Ozsaran A
Eur J Gynaecol Oncol; 2006; 27(4):389-92. PubMed ID: 17009632
[TBL] [Abstract][Full Text] [Related]
39. Parathyroid hormone-related peptide (PTH-rp) in normal, hyperplastic and malignant endometrial tissue: an immunohistochemical analysis.
Mylonas I; Makovitzky J; Shabani N; Richter DU; Jeschke U; Briese V; Friese K
Anticancer Res; 2005; 25(3A):1633-8. PubMed ID: 16033073
[TBL] [Abstract][Full Text] [Related]
40. Expression of survivin, PTEN and p27 in normal, hyperplastic, and carcinomatous endometrium.
Erkanli S; Kayaselcuk F; Kuscu E; Bagis T; Bolat F; Haberal A; Demirhan B
Int J Gynecol Cancer; 2006; 16(3):1412-8. PubMed ID: 16803539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]